Janux Therapeutics Inc. (JANX)

AI Score

Unlock

29.69

1.00 (3.49%)

At close: Apr 17, 2025, 3:59 PM

29.59

-0.34%

Pre-market: Apr 21, 2025, 07:30 AM EDT

Janux Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	430.61M	26.75M	14.66M	212.8M	19.2M	17.15M	33.7M	30.36M	51.43M	64.75M	58.4M	55.13M	35.58M	39.39M	251.63M	70.77M	7.81M	-658K
Short-Term Investments	594.57M	631.28M	631.63M	438.96M	324.82M	332.56M	269.59M	286.52M	275.59M	274.01M	295.89M	306.07M	339.38M	348.12M	142.57M	n/a	n/a	1.32M
Long-Term Investments	n/a	n/a	816K	816K	816K	816K	816K	816K	n/a	816K	816K	816K	339.38M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.7M	3.64M	2.64M	2.52M	2.51M	2.31M	2.43M	1.61M	2.21M	1.43M	207K	337K	-338.18M	140K	n/a	257K	n/a	-658K
Receivables	5.38M	n/a	12.06M	4.41M	n/a	n/a	n/a	750K	n/a	500K	n/a	n/a	n/a	n/a	375K	375K	8M	n/a
Inventory	n/a	n/a	1.00	n/a	-2.2M	-1.7M	-1.5M	n/a	n/a	1.00	-300K	-100K	-200K	-28K	n/a	n/a	n/a	n/a
Other Current Assets	n/a	8.29M	n/a	n/a	5.21M	5.48M	6.01M	3.77M	5.42M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.03B	666.32M	661.94M	658.67M	349.24M	355.19M	309.3M	321.4M	332.44M	344.33M	358.06M	364.65M	377.02M	389.59M	396.61M	71.41M	16.06M	658K
Property-Plant & Equipment	24.15M	25.06M	26.02M	26.98M	27.84M	28.52M	28.95M	29.13M	29.36M	29.18M	26.28M	2.79M	1.6M	1.36M	215K	156K	155K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	27.85M	28.7M	29.47M	30.32M	31.17M	31.66M	32.2M	31.56M	31.57M	31.43M	27.3M	3.94M	2.81M	1.5M	215K	413K	155K	-658K
Total Assets	1.06B	695.02M	691.41M	688.98M	380.41M	386.85M	341.5M	352.96M	364.01M	375.76M	385.37M	368.6M	379.82M	391.08M	396.82M	71.82M	16.22M	n/a
Account Payables	4.03M	2.46M	1.25M	2.25M	2.42M	2.5M	1.91M	2.05M	2.16M	2.87M	3M	1.94M	2.46M	3.61M	354K	857K	428K	n/a
Deferred Revenue	n/a	n/a	94K	972K	1.71M	3.65M	5.34M	4.93M	5.41M	5.91M	5.37M	4.65M	5.16M	5.26M	5.07M	3.65M	1.95M	n/a
Short-Term Debt	n/a	1.69M	1.63M	n/a	1.52M	1.46M	1.41M	1.36M	n/a	n/a	88K	153K	n/a	212K	n/a	n/a	n/a	n/a
Other Current Liabilities	4.57M	13.02M	5.01M	4.49M	2.57M	3M	6.17M	5.04M	2.67M	5.67M	3.26M	4.82M	3.81M	2.39M	3.44M	2.29M	2M	n/a
Total Current Liabilities	17.46M	17.17M	11.54M	10.61M	13.03M	14.47M	17.9M	16.11M	16.51M	16.34M	12.99M	12.52M	12.8M	12.47M	9.21M	6.89M	3.18M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	77.35M	21.62M	n/a
Total Long-Term Liabilities	21.28M	21.74M	22.19M	22.61M	23.02M	23.43M	24.13M	25.58M	26.76M	27.91M	28.56M	6.74M	700K	1.86M	2.82M	81.7M	27.67M	n/a
Total Liabilities	38.73M	38.91M	33.73M	33.22M	36.06M	37.9M	42.03M	41.69M	43.27M	44.24M	41.55M	12.52M	13.5M	14.33M	12.03M	88.59M	30.86M	n/a
Total Debt	23.02M	23.43M	23.82M	24.18M	24.54M	24.89M	25.23M	25.54M	25.3M	24.09M	23.36M	153K	194K	235K	n/a	n/a	n/a	n/a
Common Stock	59K	52K	52K	51K	46K	46K	42K	42K	42K	42K	42K	41K	41K	41K	41K	1K	1K	n/a
Retained Earnings	-237.76M	-217.54M	-189.48M	-183.52M	-168.76M	-157M	-145.44M	-127.93M	-110.47M	-94.41M	-77.71M	-60.82M	-47.41M	-33.99M	-23.23M	-17.02M	-14.74M	n/a
Comprehensive Income	2.16M	7.83M	-1.62M	-524K	665K	-1.18M	-1.06M	-739K	-1.53M	-2.28M	-1.91M	-1.57M	-270K	24K	17K	-0.00	0.00	-7.94M
Shareholders Equity	1.02B	656.1M	657.68M	655.76M	344.35M	348.95M	299.47M	311.26M	320.74M	331.51M	343.81M	356.08M	366.33M	376.75M	384.8M	-16.77M	-14.64M	-3.95M
Total Investments	594.57M	631.28M	632.45M	439.78M	324.82M	332.56M	269.59M	286.52M	275.59M	274.01M	295.89M	306.07M	339.38M	348.12M	142.57M	n/a	n/a	1.32M